ADAGIO MEDICAL HOLDINGS, INC. Business Acquisition, Pro Forma Net Income (Loss)
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Business Acquisition, Pro Forma Net Income (Loss) of -$28.99 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2025-03-27
- ADAGIO MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2024-12-31 was $0.00.
- ADAGIO MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2024-09-30 was -$12.97K.
- ADAGIO MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2023-12-31 was $0.00.
- ADAGIO MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for the quarter ending 2023-09-30 was -$10.65K.
- ADAGIO MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2024 was -$28.99K.
- ADAGIO MEDICAL HOLDINGS, INC. business acquisition, pro forma net income (loss) for fiscal 2023 was -$26.11K.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$12.97K derived: sum of 2 quarters · filed 2025-03-27 | -$28.99K 10-K · filed 2025-03-27 | |
| 2024-09-30 | -$12.97K 10-Q · filed 2024-11-14 | -$28.99K 10-Q · filed 2024-11-14 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$10.65K derived: sum of 2 quarters · filed 2025-03-27 | -$26.11K 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$10.65K 10-Q · filed 2024-11-14 | -$26.11K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |